Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-07-06 00:00:00 ET · period of report 2023-07-03 · accession 0001104659-23-078742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-07-06 | 2023-07-03 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $53.43 | -20.0K | 353.2K | -5% | -$1.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-03 | S | D | 20,000 | $53.43 | 353,226 | I Held by Chali Properties LLC | — | — | (F2) Reflects the weighted average price of sales on July 3, 2023. The shares were sold in multiple transactions at prices ranging from $52.76 to $54.10, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. |